The updated COVID-19 boosters from Pfizer Inc/BioNTech SE and Moderna helped prevent symptomatic infections against the new XBB-related subvariants, offering new evidence of how the vaccines ...
Vaccine availability is on a first-come, first-served basis and while supplies last. Updated bivalent Pfizer-BioNTech and Moderna COVID-19 vaccines and boosters will be available at the clinics. The ...
Vermont has the second lowest state fatality rate in the US (132.8 per 100K; Hawaii 104.3/100K). Mississippi (448.1/100K) and Oklahoma (445.3/100K) have the highest rates. The US average is 297.9/100K ...
CDC states that already an estimated 97% of Americans have some level of immunity, from either vaccination or infection or ...
The Moderna, Pfizer-BioNTech, and Novavax vaccines protect against many ... That said, to help maintain immunity, COVID-19 boosters and updated vaccines have been rolled out each fall since 2021. This ...
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...
GSK said in the lawsuit , opens new tab that Pfizer and BioNTech's Comirnaty vaccines ... with downbeat quarterly core profit 8:55 PM UTC · Updated ago Marketscategory Fed announces reduction ...
The lawsuit adds to a web of high-stakes U.S. court cases involving Pfizer, BioNTech and Moderna over patent royalties for technology used in their vaccines, including a case brought by Moderna ...
Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech are being dragged into another round of mRNA litigation by GSK.
April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the ...
A row between pharmaceutical firms Moderna and Pfizer/BioNTech comes to court in London on Tuesday over patents for COVID vaccine technology that helped save millions of lives during the pandemic.
But Pfizer and BioNTech deny infringement, and want two Moderna patents withdrawn as "invalid". The hearing is due to start at the High Court in London from 0930 GMT and is expected to last until ...